Ferguson Wellman Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.98M Sell
114,782
-4,184
-4% -$338K 0.11% 110
2026
Q1
$10.3M Buy
118,966
+1,120
+1% +$107K 0.14% 100
2025
Q4
$11.3M Buy
117,846
+2,453
+2% +$238K 0.18% 75
2025
Q3
$11M Buy
115,393
+2,350
+2% +$216K 0.18% 74
2025
Q2
$9.85M Buy
113,043
+2,930
+3% +$248K 0.17% 74
2025
Q1
$9.89M Buy
110,113
+7,309
+7% +$654K 0.19% 74
2024
Q4
$8.21M Sell
102,804
-2,560
-2% -$222K 0.16% 81
2024
Q3
$9.49M Buy
+105,364
New +$8.86M 0.18% 79
2024
Q2
Sell
-2,718
Closed -$237K 359
2024
Q1
$237K Sell
2,718
-408
-13% -$34.8K ﹤0.01% 342
2023
Q4
$258K Sell
3,126
-1,106
-26% -$84.3K 0.01% 336
2023
Q3
$332K Sell
4,232
-66
-2% -$5.53K 0.01% 283
2023
Q2
$379K Sell
4,298
-847
-16% -$72.9K 0.01% 276
2023
Q1
$415K Sell
5,145
-968
-16% -$78.9K 0.01% 267
2022
Q4
$475K Buy
6,113
+1,896
+45% +$154K 0.01% 257
2022
Q3
$341K Sell
4,217
-971
-19% -$87.3K 0.01% 252
2022
Q2
$466K Sell
5,188
-1,375
-21% -$139K 0.02% 230
2022
Q1
$728K Sell
6,563
-3,868
-37% -$409K 0.02% 208
2021
Q4
$1.08M Sell
10,431
-124,037
-92% -$14.4M 0.03% 177
2021
Q3
$16.9M Buy
134,468
+3,354
+3% +$434K 0.54% 59
2021
Q2
$16.3M Sell
131,114
-2,056
-2% -$258K 0.53% 58
2021
Q1
$15.7M Sell
133,170
-139,017
-51% -$16.3M 0.55% 60
2020
Q4
$31.9M Sell
272,187
-52,052
-16% -$5.73M 0.78% 33
2020
Q3
$33.7M Buy
324,239
+9,624
+3% +$967K 0.93% 34
2020
Q2
$28.9M Buy
314,615
+4,806
+2% +$461K 0.88% 36
2020
Q1
$27.9M Buy
309,809
+108,808
+54% +$11.6M 1.05% 29
2019
Q4
$22.8M Buy
201,001
+2,964
+1% +$325K 0.67% 47
2019
Q3
$21.5M Buy
198,037
+194,497
+5,494% +$20.3M 0.69% 45
2019
Q2
$345K Sell
3,540
-837
-19% -$76.4K 0.01% 279
2019
Q1
$399K Sell
4,377
-346
-7% -$31K 0.01% 262
2018
Q4
$430K Sell
4,723
-185
-4% -$17.3K 0.02% 263
2018
Q3
$483K Sell
4,908
-732
-13% -$67.7K 0.02% 241
2018
Q2
$483K Sell
5,640
-1,830
-24% -$153K 0.02% 243
2018
Q1
$599K Sell
7,470
-2,375
-24% -$196K 0.02% 233
2017
Q4
$795K Sell
9,845
-2,678
-21% -$214K 0.03% 209
2017
Q3
$974K Sell
12,523
-1,149
-8% -$95.4K 0.04% 187
2017
Q2
$1.21M Sell
13,672
-1,408
-9% -$119K 0.05% 174
2017
Q1
$1.22M Sell
15,080
-267,214
-95% -$20.9M 0.05% 176
2016
Q4
$20.1M Sell
282,294
-5,418
-2% -$426K 0.82% 42
2016
Q3
$24.9M Sell
287,712
-14,792
-5% -$1.29M 1.06% 30
2016
Q2
$26.2M Sell
302,504
-9,255
-3% -$748K 1.1% 28
2016
Q1
$23.4M Buy
311,759
+2,015
+0.7% +$152K 0.99% 33
2015
Q4
$23.8M Sell
309,744
-1,999
-0.6% -$150K 0.98% 29
2015
Q3
$20.9M Sell
311,743
-138,296
-31% -$10.2M 0.93% 36
2015
Q2
$33.3M Sell
450,039
-1,221
-0.3% -$93.3K 1.38% 15
2015
Q1
$35.2M Buy
451,260
+64,203
+17% +$4.87M 1.45% 15
2014
Q4
$27.9M Buy
387,057
+206,110
+114% +$14.3M 1.12% 27
2014
Q3
$11.2M Buy
180,947
+172,065
+1,937% +$10.9M 0.48% 67
2014
Q2
$566K Buy
8,882
+355
+4% +$21.6K 0.02% 224
2014
Q1
$525K Sell
8,527
-1,008
-11% -$58.7K 0.02% 217
2013
Q4
$547K Sell
9,535
-225
-2% -$12.8K 0.02% 210
2013
Q3
$520K Sell
9,760
-1,185
-11% -$63.8K 0.03% 207
2013
Q2
$563K Buy
+10,945
New +$541K 0.04% 123

Other funds holding MDT

Ferguson Wellman Capital Management's MDT Position: Q2 2026 in Review

Ferguson Wellman Capital Management reduced its Medtronic (MDT) stake by 3.5% in Q2 2026, selling an estimated $338K and leaving 114,782 shares worth $8.98M. The position accounts for 0.11% of the portfolio, ranked #110.

Ferguson Wellman Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.2M in Q1 2015. 694 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ferguson Wellman Capital Management held 114,782 shares of Medtronic worth $8.98M as of Q2 2026.
  • Ferguson Wellman Capital Management sold 4,184 Medtronic shares in Q2 2026, an estimated $338K.
  • Medtronic made up 0.11% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #110 holding.
  • Ferguson Wellman Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Ferguson Wellman Capital Management's Medtronic position peaked at $35.2M in Q1 2015.
  • 694 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.